MBX BIOSCIENCES, INC. (MBX)

(85% Positive) MBX BIOSCIENCES, INC. (MBX) Announces Enrollment Update for canvuparatide Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment